Key result
Donor-derived transmission of coxsackievirus serogroup-3 resulted in mild clinical syndromes in solid organ transplant recipients.
Case Report
Answers are grounded in this paper and cite their sources.
This first reported case of donor-derived coxsackievirus B3 transmission highlights the need for ongoing surveillance of a broad range of pathogens in solid organ transplantation.
Unexpected donor-to-recipient infectious disease transmission is an important, albeit rare, complication of solid organ transplantation. Greater work and understanding about the epidemiology of these donor-derived transmissions is continually required to further mitigate this risk. Herein we present the first reported case of proven donor-derived transmission of coxsackievirus serogroup-3, an enterovirus, following solid organ transplant. Swift and effective communication between the organ donation agency, treating physicians, laboratory testing and notification ensured a coordinated approach. The resulting clinical syndromes in the organ recipients were mild. This case highlights the requirement for ongoing surveillance over a broad range of infecting pathogens that may present as a donor-derived infection.
No takes yet. Share an insight, caveat, or question.
Abbott et al. (2015) conducted a case report in Solid organ transplantation / donor-derived infection. Donor-derived transmission of coxsackievirus serogroup-3 was evaluated on Clinical syndrome in organ recipients. Donor-derived transmission of coxsackievirus serogroup-3 resulted in mild clinical syndromes in solid organ transplant recipients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: